D. Akech

发表

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

L. Hammitt, J. Scott, I. Adetifa, 2019, The Lancet. Global health.

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021

J. Scott, C. Agoti, P. Bejon, 2022, medRxiv.

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya

Quentin J. Leclerc, Carl A. B. Pearson, O. Brady, 2020, BMC Medicine.

Impact of 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya

K. Marsh, L. Hammitt, J. Scott, 2018, bioRxiv.

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies

L. Hammitt, J. Scott, S. Sharif, 2014, The Lancet. Global health.

The merits of sustaining pneumococcal vaccination after transitioning from Gavi support – a modelling and cost-effectiveness study for Kenya

L. Hammitt, I. Adetifa, U. Griffiths, 2018, bioRxiv.

Predicted serotype distribution in invasive pneumococcal disease (IPD) among children less than five years prior to the introduction of the Pneumococcal Conjugate Vaccine (PCV) in Nigeria

J. Scott, I. Adetifa, I. Abubakar, 2022, medRxiv.

ect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus infl uenzae in Kilifi , Kenya: fi ndings from cross-sectional carriage studies

L. Hammitt, A. Karani, D. Akech, 2018 .

Nasopharyngeal competition dynamics are likely to be altered following vaccine introduction: bacteriocin prevalence and diversity among Icelandic and Kenyan pneumococci

Andries J. van Tonder, S. Bentley, A. Akter, 2022, bioRxiv.

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

K. Marsh, L. Hammitt, J. Scott, 2019, The Lancet.

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data

K. Auranen, L. Hammitt, J. Scott, 2017, Vaccine.

A Preliminary Study of Pneumonia Etiology Among Hospitalized Children in Kenya

Dustin G Gibson, David R Murdoch, D. Murdoch, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria

J. Scott, I. Adetifa, I. Abubakar, 2022, medRxiv.

Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys.

J. Scott, L. Hammitt, I. Adetifa, 2023, The Lancet. Infectious diseases.

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022

J. Scott, M. Kimani, I. Adetifa, 2022, medRxiv.

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022

M. Kimani, P. Bejon, I. Adetifa, 2023, Influenza and other respiratory viruses.